Its a new way to measure liver scarring that means no needles for patients. 
Rodney Reamer is a hairstylist, so every night Mikey and Lucy reap the benefits. 
Right now, he’s easing back into work. 30 years of battling Hepatitis-C took its toll.
Rodney Reamer said, “I knew something was eventually going to happen to my liver. It just depended on when. It wasn’t if, it was going to be when.”
Scarring of fibrosis can be progressive.
Paul Thuluvath, MD, FRCP Professor of Medicine, Mercy Medical Center & University of Maryland School of Medicine said, “There is a risk of that person developing cancer.”
4 years ago, doctors diagnosed Rodney with liver cancer. Chemotherapy and transplant surgery wiped him out. 
Rodney Reamer said, “When I went to the hospital I knew I had, at best, a 50-50 shot of coming out.” 
Rodney beat the odds. But doctors will need to monitor his liver for the rest of his life. 
Paul Thuluvath, MD, FRCP said, “The conventional test is a liver biopsy.  It is safe. It can be done under local anesthesia, but it is an invasive test.”
Instead, doctor Paul Thuluvath is using a new non-invasive method to monitor scarring. 
The Fibroscan works like an ultrasound, doctors place the tip of a wand at a precise point on the patient’s side. Sound waves measure the stiffness of the liver.  The harder the liver, the more serious the scarring. 
After years of procedures for Rodney, a no-needle option keeps him moving toward recovery. 
The Fibroscan test takes about 5 to 10 minutes, and the results are immediate. Doctor Thuluvath says a liver biopsy is still the gold standard for assessing fibrosis; However, he says the Fibroscan test, in combination with blood work may help doctors determine which patients can be excluded from regular biopsies.